| abstract |
The invention relates to ROCK kinase inhibitors, pharmaceutical compositions, in particular drugs, including such inhibitors, and the use of such inhibitors in the treatment and prevention of diseases in which ROCK is involved. In particular, the present invention relates to compounds of the formula I or stereoisomers, tautomers, racemic compounds, salts, hydrates or solvates based on them. |